Home
Medical News
Lastet 10 Medical News
U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
FDA. New and Generic Drug Approvals - January 27, 2012
FDA. New and Generic Drug Approvals - January 26, 2012
FDA. New and Generic Drug Approvals - January 25, 2012
FDA. New and Generic Drug Approvals - January 24, 2012
FDA. New and Generic Drug Approvals - January 23, 2012
FDA. New and Generic Drug Approvals - January 20, 2012
Dictionary
Browse alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
W
V
Y
Z
Drugs A-Z
Browse alphabetically Medicines Human:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Orfan Drugs
Browse alphabetically Supplements:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Wiew Veterinary medicines:
All Veterinary medicines
Health articles
Choose category
Herbal Articles
Toxic Substances A-Z Index
Parasitic Diseases
Mendeleev periodic table
Pharmaceutical companies
Medicinal plants list
EU Drugs
Cosmetics
Be eco! Be organic!
List of Vitamins
List of Minerals
Active substances and excipients
Medical Tests. Diagnostics
Health Organizations
Symptoms and signs of disease
List of Diseases
Drug manufacturers
Choose country
UK
Canada
USA
Denmark
Greece
Norway
Poland
Portugal
Germany
France
Japan
Brazil
Sweden
Italy
Spain
China
Argentina
Czech Republic
Hospitals Worldwide
Choose country
Australia
Brazil
Canada
India
Ireland
Israel
Malaysia
Mexico
Netherlands
Nigeria
Saudi Arabia
South Africa
Spain
Switzerland
USA
UK
Search drugs:
Home
-
Drugs and Supplements A-Z
Drugs and Sepplements. Supplements K
KAL Pantothenic Acid 250 mg, Nutraceutical Corp.
KAL Papaya Zyme Chewable, Nutraceutical Corp.
KAL Papaya Zyme Plus, Nutraceutical Corp.
KAL Peptic Defense, Nutraceutical Corp.
KAL Phosphatidyl Choline 425 mg, Nutraceutical Corp.
Kal Phosphatidylserine 100 mg, Nutraceutical Corp.
KAL Potassium 99 Chloride, Nutraceutical Corp.
KAL Potassium 99 Proteinate, Nutraceutical Corp.
KAL Primrose Oil 500 mg, Nutraceutical Corp.
KAL Progesterone PM, Nutraceutical Corp.
KAL Pure Colon Therapy, Nutraceutical Corp.
KAL Pure Silver Therapy, Nutraceutical Corp.
KAL Pure Stevia & Fiber, Nutraceutical Corp.
KAL Pure Stevia Extract Liquid, Nutraceutical Corp.
KAL Pure Stevia Extract Powder, Nutraceutical Corp.
KAL Pure Stevia Organic Extract, Nutraceutical Corp.
KAL Pycnogenol 50 mg, Nutraceutical Corp.
KAL Pycnogenol 75 mg, Nutraceutical Corp.
KAL Quercetin 1000 mg, Nutraceutical Corp.
KAL Red Yeast Rice, CoQ10, Omega 3, Nutraceutical Corp.
KAL Rendezvous for Him, Nutraceutical Corp.
KAL Resveratrol 25 mg, Nutraceutical Corp.
KAL Rutin 250 mg, Nutraceutical Corp.
KAL S.O.D. 2000, Nutraceutical Corp.
KAL S.O.D. 3, Nutraceutical Corp.
KAL SAMe 200 mg, Nutraceutical Corp.
KAL Selenium 100 mcg Yeast Free, Nutraceutical Corp.
KAL Selenium 100 mcg, Nutraceutical Corp.
KAL Selenium 200 mcg, Nutraceutical Corp.
KAL Selenium 50 mcg, Nutraceutical Corp.
KAL Silica Plus, Nutraceutical Corp.
KAL Sleep Success, Nutraceutical Corp.
KAL Stevia Syrup, Nutraceutical Corp.
KAL Stomach Acid Defense, Nutraceutical Corp.
KAL Stress 1, Nutraceutical Corp.
KAL Stress B Complex, Nutraceutical Corp.
KAL Super Enzymes, Nutraceutical Corp.
KAL Super Silica Plus, Nutraceutical Corp.
KAL Tea Tree Water Soluble, Nutraceutical Corp.
KAL Throat Releev Lozenge (orange or cherry flavor), Nutraceutical Corp.
Previous
1
2
...
6
7
8
9
10
11
12
...
30
31
Next
General Search
Latest News
U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
FDA. New and Generic Drug Approvals - January 27, 2012
Latest Drugs
Efavirenz Teva
Desloratadine Actavis
Repaglinide Accord
Emselex
Hepsera
Zulvac 1 Ovis
Zulvac 1 Bovis
Levetiracetam Sun
Inovelon
Olanzapine Glenmark Europe
Last medical tags:
Torisel
,
temsirolimus
,
Inlyta
,
chronic myeloid leukemia
,
bosutinib
,
Inlyta
,
renal cell carcinoma
,
kidney cancer
,
myelin
,
Tysabri
,
natalizumab
,
brain infection
,
progressive multifocal leukoencephalopathy
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
thoracic aortic transection
,
endovascular graft
,
methotrexate
,
Voraxaze
,
cancer chemotherapy drug
,
glucarpidase
,
Adcetris
,
bleomycin
,
multifocal leukoencephalopathy
,
CardioGen-82
,
radiation
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
raltegravir
,
Isentress
,
antiretroviral medicines
,
Theravance
,
Relovair
,
asthma
,
fluticasone
,
bronchitis
,
neuromuscular disease
,
SMA
,
muscle atrophy
,
Resolor
,
prokinetic
,
prucalopride
,
ADHD
,
psychiatric behavioural disorder
,
Venvanse
,
lisdexamfetamine dimesylate
,
type 2 diabetes mellitus
,
Actoplus Met XR
,
pioglitazone
,
Mylan
,
Eprosartan Mesylate Tablets
,
Teveten
,
antimicrobials
,
cephapirin
,
cephalosporin
,
teriflunomide
,
Rebif
,
alanine aminotransferase levels
,
flu-like symptoms
,
multiple sclerosis
,
electrical pulses
,
implantable pulse generator
,
Precision Plus Spinal Cord Stimulator
,
genetic blood clotting disorder
,
hemophilia A
,
Advate
,
bleeding episodes
,
heart failure
,
heart transplantation
,
Pediatric Medical Device Safety
,
pulsatile cardiac assist device
,
selective serotonin reuptake inhibitor
,
SSRI
,
pulmonary hypertension
,
» All tags
Sitemap